Organization & Developments: Akonni

Parents

2010: Has over 20 patents issued with 13 others pending (2010)
Akonni Biosystems Awarded $3M NIH Challenge Grant
Akonni:Product Developments
Commercial products and products in its near-term pipeline include rapid sample preparation methodologies for nucleic acid extraction and multiplex panel assays for detecting multidrug-resistant tuberculosis (MDR-TB), upper respiratory infections, viral en
Molecular diagnostics (MDx) company that develops, manufactures, and markets integrated molecular diagnostic systems.
Multiplexed analyses of clinical samples such as culture, blood, saliva, nasal swab and urine can be performed in 15 minutes for
The company’s core technology is based on work developed at Argonne National Laboratory and the Engelhardt Institute of Molecular Biology and utilizes gel-drop array technologies optimized for medical applications.
This is accomplished by combining in an end-to-end workflow several highly complex laboratory processes, including steps for sam